Apurinic/Apyrimidinic Endonuclease 2 (APEX2)

[Edit]

APEXL2; APE2; XTH2; APEX Nuclease 2; DNA-(apurinic or apyrimidinic site) lyase 2; AP endonuclease XTH2

Apurinic/Apyrimidinic Endonuclease 2 (APEX2)
APEX2 is a member of the apurinic/apyrimidinic (AP) family of endonucleases that initiate the repair of AP sites formed by spontaneous hydrolysis of the N-glycosylic bond, mutagen-induced base release, or damaged-base excision by a DNA repair glycosylase. The deduced 518-amino acid protein has a calculated molecular mass of 59.1 kD. APEX2 contains a predicted N-terminal mitochondrial targeting sequence, a C-terminal region that shares homology with S. cerevisiae APN2/ETH1, a putative PCNA-binding motif, and a C-terminal subregion that is homologous to a tandem repeat in the C-terminal region of DNA topoisomerase III family proteins. RT-PCR detected APEX2 expression in HeLa cells, Jurkat cells, and human kidney, brain and fetal brain tissue.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Apurinic/Apyrimidinic Endonuclease 2 (APEX2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Apurinic/Apyrimidinic Endonuclease 2 (APEX2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Apurinic/Apyrimidinic Endonuclease 2 (APEX2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Apurinic/Apyrimidinic Endonuclease 2 (APEX2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Apurinic/Apyrimidinic Endonuclease 2 (APEX2) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Apurinic/Apyrimidinic Endonuclease 2 (APEX2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Apurinic/Apyrimidinic Endonuclease 2 (APEX2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Apurinic/Apyrimidinic Endonuclease 2 (APEX2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Apurinic/Apyrimidinic Endonuclease 2 (APEX2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Apurinic/Apyrimidinic Endonuclease 2 (APEX2) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Apurinic/Apyrimidinic Endonuclease 2 (APEX2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Apurinic/Apyrimidinic Endonuclease 2 (APEX2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Apurinic/Apyrimidinic Endonuclease 2 (APEX2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Apurinic/Apyrimidinic Endonuclease 2 (APEX2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Apurinic/Apyrimidinic Endonuclease 2 (APEX2) ELISA Kit Customized Service Offer
  1. "Human APE2 protein is mostly localized in the nuclei and to some extent in the mitochondria, while nuclear APE2 is partly associated with proliferating cell nuclear antigen."Nucleic Acids Res. 29:2349-2360(2001) [PubMed] [Europe PMC] [Abstract]
  2. "The DNA sequence of the human X chromosome." Nature 434:325-337(2005) [PubMed] [Europe PMC] [Abstract]
  3. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  4. "Human Ape2 protein has a 3'-5' exonuclease activity that acts preferentially on mismatched base pairs."Nucleic Acids Res. 34:2508-2515(2006) [PubMed] [Europe PMC] [Abstract]
  5. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  6. "Role of PCNA-dependent stimulation of 3'-phosphodiesterase and 3'-5' exonuclease activities of human Ape2 in repair of oxidative DNA damage."Nucleic Acids Res. 37:4247-4255(2009) [PubMed] [Europe PMC] [Abstract]
  7. "Identification of rare DNA variants in mitochondrial disorders with improved array-based sequencing."Nucleic Acids Res. 39:44-58(2011) [PubMed] [Europe PMC] [Abstract]